Fred Hutchinson Cancer Research Center's Dr. Ruth Etzioni and colleagues show aggressive treatment confers only modest extension of life; model confirms active surveillance offers patients years free of treatment and side effects
Basic Sciences researcher’s innovative mathematical analysis of fundamental biology garners $1.5 million in funding
Sept. 28, 2009
| By Colleen Steelquist
For her novel work analyzing cooperative systems and cheater mechanisms in yeast cells, Dr. Wenying Shou is the first Fred Hutchinson Cancer Research Center investigator to win a National Institutes of Health New Innovator Award. The three-year-old program, which encourages high-risk research and innovation for early stage investigators, granted 55 awards nationwide. Shou’s five-year award is worth up to $1.5 million.